Endotracheal Tube Biofilm Dynamics in Critical Care

Biofilm formation on endotracheal tubes (ETTs) is an early and pervasive event in mechanically ventilated patients. Microbial cells adhere to the inner lumen of the tube, secrete an extracellular matrix and undergo maturation before dispersal, creating a reservoir of pathogens that can seed the lower respiratory tract. The dynamic interplay between bacterial and fungal species—most notably Pseudomonas aeruginosa and Staphylococcus epidermidis—shapes the composition, density and antibiotic susceptibility of the biofilm. Temporal studies have revealed that biofilm accumulation begins within hours of intubation and evolves under the influence of tube material, airway secretions and host factors. Persistent biofilms contribute to the pathogenesis of ventilator-associated pneumonia (VAP) by shielding microbes from innate immunity and systemic antimicrobials, thereby promoting treatment failure and relapse. Advances in imaging, molecular profiling and in vitro modelling have elucidated key stages of biofilm development, informed novel detection methods and spurred the design of antimicrobial surface treatments. This body of work holds global significance for intensive care practice, offering practical avenues for reducing VAP incidence, tailoring antibiotic dosing and improving patient outcomes.

Research from Nature Portfolio

Recent studies have characterised the microbial consortium on ETT surfaces and its prognostic value. By applying high-resolution 16S rRNA and fungal ITS sequencing to biofilm samples from extubated tubes, investigators have shown that a higher relative abundance of Pseudomonadaceae correlates inversely with patient survival, while the proportion of Staphylococcaceae further refines outcome prediction. A decision-tree model incorporating microbial composition and patient age accurately stratifies risk, underscoring the importance of microbiome profiling as both a diagnostic and prognostic tool in critical care settings.

Endotracheal Tube Biofilm Dynamics in Critical Care publication trend

The graph below shows the total number of articles in endotracheal tube biofilm dynamics in critical care across all publications each year (not limited to Nature Index journals).

Technical terms

Biofilm: A structured community of micro-organisms encased in a self-produced polymeric matrix attached to a surface, conferring enhanced survival and antimicrobial tolerance.

Endotracheal tube (ETT): A medical device inserted into the trachea to secure an airway and deliver mechanical ventilation to critically ill patients.

Ventilator-associated pneumonia (VAP): An infection of the lower respiratory tract arising in patients after at least 48 hours of invasive mechanical ventilation.

Pharmacokinetic/pharmacodynamic model: An experimental framework that integrates drug concentration profiles with microbial responses to predict antibiotic efficacy under simulated physiological conditions.

Antimicrobial coating: A surface modification designed to release or present active agents that inhibit microbial adhesion and biofilm development on medical devices.

References

1. Optimization of an in vitro Pseudomonas aeruginosa Biofilm Model to Examine Antibiotic Pharmacodynamics at the Air-Liquid Interface. npj Biofilms and Microbiomes (2024).
2. Co-immobilization of Ciprofloxacin and Chlorhexidine as a Broad-Spectrum Antimicrobial Dual-Drug Coating for Poly(vinyl chloride) (PVC)-Based Endotracheal Tubes. ACS Applied Materials & Interfaces (2024).
3. Polymyxin B Peptide Hydrogel Coating: A Novel Approach to Prevent Ventilator-Associated Pneumonia. International Journal of Molecular Sciences (2024).
4. The endotracheal tube microbiome associated with Pseudomonas aeruginosa or Staphylococcus epidermidis. Scientific Reports (2016).